OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.?
No data available
One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity.
Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helps them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver.
https://www.onenucleus.com
Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helps them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver.
https://www.onenucleus.com
cancer profiling, diagnostics
new antibiotics class
Optimum is an international strategic healthcare communications firm, specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. We are experienced and trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, biotech, digital health and healthcare services, large and small.
Watch our Member Showcase Video https://bit.ly/3FFKIIz
Watch our Member Showcase Video https://bit.ly/3FFKIIz
Our Biosciences Team has advised on a wide variety of matters including research and development agreements, patent and know how licences and assignments, manufacturing agreements, bioinformatics, regulatory matters, clinical trials, patent litigation and competition law. The members of the Biosciences Team pride themselves on their responsive, hands-on and pro-active approach. This includes helping to find venture capital finance for clients through the firm's extensive corporate finance network and advising on intellectual property protection and exploitation. Osborne Clarke recognises that biotechnology companies want to deal with a team of specialists whose experience ensures technically accurate and commercial, pragmatic advice.. . Biotechnology agreements, collaborations, research and devleopment agreements, venture capital and other funding arrangements for biotechnology companies. Represented in most major European jurisdictions and in Silicon Valley.. . Bioinformatics, law, European law, research, colllaboration, contract research, intellectual property, patents, financing, competition law, technology transfer, mergers and acquisitions, due diligence, regulatory matters.
Ovartix is a women’s health drug discovery company that harnesses large-scale human multi-omics data, state-of-the-art cell engineered and animal models to identify, validate and develop next-generation therapeutics for ovary-centric female reproductive disorders, such as infertility and menopause
Sustainable bio-based materials for fashion
No data available